Oxford Begins First Human Trials for Bundibugyo Ebola Vaccine

The University of Oxford has officially launched the first human trial for a vaccine specifically targeting the Bundibugyo strain of Ebola, marking a critical step in global efforts to combat the deadly virus. This trial represents a significant advancement in developing defenses against this particular strain.

13 Jul, 22:24 — 14 Jul, 22:25

Post Share

Why this matters

Bundibugyo ebolavirus is one of several species of Ebola that can cause severe disease in humans, and there is currently no approved vaccine specifically for it. This trial represents a critical step towards developing a preventative measure against this particular strain, especially given ongoing outbreaks in regions like the Democratic Republic of Congo.

Key entitiesUniversity of Oxford Bundibugyo ebolavirus Democratic Republic of Congo

The Story

What 3 sources agree on, dispute, and miss

What sources agree on

The first human trial for a Bundibugyo Ebola vaccine has begun
The trial is being conducted by the University of Oxford
The trial will assess the vaccine's safety and immune response

Key claims2 agreed

✓

The early-stage trial will enroll 50 healthy adults.

agreed·japan-times

✓

The vaccine aims to combat an outbreak spreading in the Democratic Republic of Congo.

agreed·myjoyonline

The Story

Analyzing sources…

Source Diversity

Moderate (46/100)

3 sources25/33

Spectrum spread— 2/5 buckets covered8/33

Far L

Left1

Left (1)

japan-times

Center2

Center (2)

actualite-cdmyjoyonline

Right

Far R

Geographic diversity— 3 regions13/34

DR Congo1Japan1Ghana1

Political spectrum

LeftCenterRight

japan-times

myjoyonline

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

japan-timescentercenter-leftneutralMostly Factualfactual reporting on scientific development

myjoyonlinecentercenterneutralMixedstraightforward reporting of medical research

Coverage leans: balanced

The coverage from both outlets is largely factual and neutral, focusing on the scientific details of the vaccine trial without apparent political leanings.

Sources

Showing 3 of 3 sources

japan-timesMostly Factual25d ago

First human trial of Bundibugyo Ebola vaccine begins

The early-stage trial will enroll 50 healthy adults to assess the vaccine's safety and immune response.

Read full article →

myjoyonlineMixed25d ago

Oxford begins first human trial of Bundibugyo Ebola vaccine

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to combat an outbreak spreading in the Democratic Republic of Congo ‌and Uganda.

By Abubakar Ibrahim

Read full article →

actualite-cdMixed24d ago

Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN

Oxford launches first human trials for Bundibugyo Ebola vaccine MSN

Read full article →

Coverage Timeline

First report: myjoyonline · 13 Jul, 22:24|Full coverage: 3 · 1d|Window: 1d

Left-leaningCenterRight-leaning

myjoyonline13 Jul, 22:24First to report

Oxford begins first human trial of Bundibugyo Ebola vaccine

5h later

japan-times14 Jul, 03:53

First human trial of Bundibugyo Ebola vaccine begins

19h later

actualite-cd14 Jul, 22:25Latest update

Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN

Story evolution

Trial Launch AnnouncementJuly 13-14, 2026

The University of Oxford announced the commencement of the first human trial for the Bundibugyo Ebola vaccine.

PERSPECTA

PERSPECTA

Oxford Begins First Human Trials for Bundibugyo Ebola Vaccine

Why this matters

The Story

What sources agree on

Key claims2 agreed

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

First human trial of Bundibugyo Ebola vaccine begins

Oxford begins first human trial of Bundibugyo Ebola vaccine

Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN

Coverage Timeline

Oxford begins first human trial of Bundibugyo Ebola vaccine

First human trial of Bundibugyo Ebola vaccine begins

Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN

Story evolution

Related Stories

Experts Urge Early Preparation for Hotter Summers, Beyond Air Conditioning

Excessive Protein Intake Poses Risks to Kidneys and Increases Cancer Risk

Human Lifespan Could Reach 200 Years, Limited by Cell Damage

Medicare Patient Faces Double Deductible Payment After Short Hospital Stay

PERSPECTA

Political spectrum

Why this matters

Story evolution

The Story

What sources agree on

Key claims2 agreed